Generics - Diabetes, Takeda Pharmaceuticals

Filter

Popular Filters

Ranbaxy debuts authorized Actos generic in USA, followed by Teva and Mylan

20-08-2012

The US subsidiary of Ranbaxy Laboratories (AB: BO), India's largest drugmaker, has launched authorized…

ActoplusMetActosDiabetesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaRanbaxy LaboratoriesRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Watson sues US FDA regarding generic Actos approval delay

16-08-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) says it has filed suit against the US Food and…

ActosDiabetesGenericsLegalNorth AmericaTakeda PharmaceuticalsWatson Pharmaceuticals

Mylan confirms Actoplus patent challenge

09-01-2012

US generic drugmaker Mylan (Nasdaq: MYL) has confirmed that it has been sued by Takeda Pharmaceutical…

AndrxDiabetesGenericsLegalMylan LaboratoriesNorth AmericaPatentsTakeda PharmaceuticalsWatson Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top